Co-Diagnostics, Inc. Balance Sheet
CODX|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Co-Diagnostics, Inc. had $25M in total assets and $21M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.9M | $2.9M | $14.9M | $23.0M | $88.6M | $43.0M | $893.1K | $3.5M | $998.7K |
| Accounts Receivable | $190.4K | $132.6K | $303.9K | $3.5M | $20.8M | $12.1M | $131.4K | $13.4K | - |
| Inventory | $992.4K | $1.1M | $1.7M | $5.3M | $2.0M | $8.0M | $197.2K | $18.2K | $9.1K |
| Current Assets | $13.7M | $32.3M | $62.1M | $92.7M | $115.1M | $68.4M | $1.6M | $1.1M | $4.5M |
| PP&E (Net) | $2.3M | $2.8M | $3.0M | $2.5M | $1.9M | $949.6K | $196.8K | $156.1K | $165.6K |
| Goodwill | - | - | - | $14.7M | $14.7M | - | - | - | - |
| Total Assets | $24.7M | $63.6M | $95.3M | $123.1M | $160.0M | $71.2M | $2.2M | $1.6M | $4.7M |
| Current Liabilities | $3.5M | $7.3M | $5.7M | $3.9M | $12.6M | $4.5M | $328.1K | $2.4M | $628.3K |
| Total Debt | - | - | - | - | - | - | - | $1.9M | - |
| Shareholders' Equity | $20.6M | $53.9M | $85.6M | $134.5M | $66.7M | $1.7M | -$1.1M | $3.9M | -$3.0M |